EMD-27826
Cryo-EM structure of the full-length human NF1 dimer
EMD-27826
Single-particle3.6 Å

Map released: 26/04/2023
Last modified: 12/06/2024
Sample Organism:
Homo sapiens
Sample: Full-length human NF1
Fitted models: 8e20 (Avg. Q-score: 0.323)
Deposition Authors: Darling JE, Merk A, Grisshammer R, Ognjenovic J
Sample: Full-length human NF1
Fitted models: 8e20 (Avg. Q-score: 0.323)
Deposition Authors: Darling JE, Merk A, Grisshammer R, Ognjenovic J
Destabilizing NF1 variants act in a dominant negative manner through neurofibromin dimerization.
Young LC
,
Goldstein de Salazar R,
Han SW
,
Huang ZYS
,
Merk A,
Drew M
,
Darling J,
Wall V
,
Grisshammer R,
Cheng A
,
Allison MR,
Sale MJ,
Nissley DV
,
Esposito D
,
Ognjenovic J,
McCormick F
(2023) PNAS , 120 , e2208960120 - e2208960120









(2023) PNAS , 120 , e2208960120 - e2208960120
Abstract:
The majority of pathogenic mutations in the neurofibromatosis type I (NF1) gene reduce total neurofibromin protein expression through premature truncation or microdeletion, but it is less well understood how loss-of-function missense variants drive NF1 disease. We have found that patient variants in codons 844 to 848, which correlate with a severe phenotype, cause protein instability and exert an additional dominant-negative action whereby wild-type neurofibromin also becomes destabilized through protein dimerization. We have used our neurofibromin cryogenic electron microscopy structure to predict and validate other patient variants that act through a similar mechanism. This provides a foundation for understanding genotype-phenotype correlations and has important implications for patient counseling, disease management, and therapeutics.
The majority of pathogenic mutations in the neurofibromatosis type I (NF1) gene reduce total neurofibromin protein expression through premature truncation or microdeletion, but it is less well understood how loss-of-function missense variants drive NF1 disease. We have found that patient variants in codons 844 to 848, which correlate with a severe phenotype, cause protein instability and exert an additional dominant-negative action whereby wild-type neurofibromin also becomes destabilized through protein dimerization. We have used our neurofibromin cryogenic electron microscopy structure to predict and validate other patient variants that act through a similar mechanism. This provides a foundation for understanding genotype-phenotype correlations and has important implications for patient counseling, disease management, and therapeutics.